Filter by: patients
What is Diphenhydramine (IV or IM)?

Diphenhydramine IV/IM is an antihistamine. It is given via intramuscular injection or intravenously to treat and prevent allergic reactions.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Stomach problems 1 0
Itching (pruritus) 1 0
Counting at night/can't sleep 1 0
Stomach (gastric) ulcer pain 1 0
Allergies 1 0
Autoimmune Urticaria 1 1 Efficacy_major

See all 7 patients currently taking Diphenhydramine (IV or IM)

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
2
None
0

Commonly reported side effects, conditions, and hospitalizations associated with Diphenhydramine (IV or IM)

Fatigue 1
Somnolence 1

Reported Dosages

  2 25mg as needed 50 mg monthly 25 mg daily 100 mg daily 150 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Diphenhydramine (IV or IM) (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 1   Course of treatment ended: 50%

See all 1 patient who’ve stopped taking Diphenhydramine (IV or IM)

Currently Taking Diphenhydramine (IV or IM)

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Diphenhydramine (IV or IM)

Always
1 50%
Usually
0 0%
Sometimes
0 0%
Never
1 50%

Burden

Difficulty being on treatment

Burden of Diphenhydramine (IV or IM)

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
2 100%

Cost

Paid out of pocket

Cost of Diphenhydramine (IV or IM)

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.